Plasma free hemoglobin management and renal protection effects in patients with artificial heart and lungs having congenital heart disease: A dosing strategy for haptoglobin, using Hemocue<sup>®</sup> readings as an indicator
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.